BACKGROUND: Mutations in genes encoding subunits of the tRNA-splicing endonuclease (TSEN) complex were identified in patients with pontocerebellar hypoplasia 2 (PCH2) and pontocerebellar hypoplasia 4 (PCH4). OBJECTIVE: We report molecular genetic findings in 12 Italian patients with clinical and MRI findings compatible with PCH2 and PCH4. METHODS: We retrospectively selected a cohort of 12 children from 9 Italian families with MRI of hypoplastic pontocerebellar structures and clinical manifestations suggesting either PCH2 or PCH4 and submitted them to direct sequencing of the genes encoding the 4 subunits of the TSEN complex, namely TSEN54, TSEN34, TSEN15, and TSEN2. RESULTS: In a cohort of 12 children, we detected the common p.A307S mutation in TSEN54 in 9/12 available patients from nine unrelated families. We also detected a novel c.1170_1183del (p. V390fs39X) in compound heterozygosity with the common p.A307S in a child with a severe PCH4 phenotype. In another severely affected patient, the second mutant allele was not identified. Two sibs without mutations in the TSEN complex were unlinked to the PCH3 locus. In addition to typical clinical and neuroradiologic features of PCH2, both children were affected by a tubulopathy resembling Bartter syndrome. CONCLUSIONS: We confirm that the common p.A307S mutation in TSEN54 is responsible for most of the patients with a PCH2 phenotype. The presence of a heterozygous in/del variant correlates with a more severe phenotype as PCH4. In addition, we describe a new clinical form of PCH in 2 sibs with clinical and MRI features of PCH2.
BACKGROUND: Mutations in genes encoding subunits of the tRNA-splicing endonuclease (TSEN) complex were identified in patients with pontocerebellar hypoplasia 2 (PCH2) and pontocerebellar hypoplasia 4 (PCH4). OBJECTIVE: We report molecular genetic findings in 12 Italian patients with clinical and MRI findings compatible with PCH2 and PCH4. METHODS: We retrospectively selected a cohort of 12 children from 9 Italian families with MRI of hypoplastic pontocerebellar structures and clinical manifestations suggesting either PCH2 or PCH4 and submitted them to direct sequencing of the genes encoding the 4 subunits of the TSEN complex, namely TSEN54, TSEN34, TSEN15, and TSEN2. RESULTS: In a cohort of 12 children, we detected the common p.A307S mutation in TSEN54 in 9/12 available patients from nine unrelated families. We also detected a novel c.1170_1183del (p. V390fs39X) in compound heterozygosity with the common p.A307S in a child with a severe PCH4 phenotype. In another severely affected patient, the second mutant allele was not identified. Two sibs without mutations in the TSEN complex were unlinked to the PCH3 locus. In addition to typical clinical and neuroradiologic features of PCH2, both children were affected by a tubulopathy resembling Bartter syndrome. CONCLUSIONS: We confirm that the common p.A307S mutation in TSEN54 is responsible for most of the patients with a PCH2 phenotype. The presence of a heterozygous in/del variant correlates with a more severe phenotype as PCH4. In addition, we describe a new clinical form of PCH in 2 sibs with clinical and MRI features of PCH2.
Authors: Ender Karaca; Stefan Weitzer; Davut Pehlivan; Hiroshi Shiraishi; Tasos Gogakos; Toshikatsu Hanada; Shalini N Jhangiani; Wojciech Wiszniewski; Marjorie Withers; Ian M Campbell; Serkan Erdin; Sedat Isikay; Luis M Franco; Claudia Gonzaga-Jauregui; Tomasz Gambin; Violet Gelowani; Jill V Hunter; Gozde Yesil; Erkan Koparir; Sarenur Yilmaz; Miguel Brown; Daniel Briskin; Markus Hafner; Pavel Morozov; Thalia A Farazi; Christian Bernreuther; Markus Glatzel; Siegfried Trattnig; Joachim Friske; Claudia Kronnerwetter; Matthew N Bainbridge; Alper Gezdirici; Mehmet Seven; Donna M Muzny; Eric Boerwinkle; Mustafa Ozen; Tim Clausen; Thomas Tuschl; Adnan Yuksel; Andreas Hess; Richard A Gibbs; Javier Martinez; Josef M Penninger; James R Lupski Journal: Cell Date: 2014-04-24 Impact factor: 41.582
Authors: Maha S Zaki; Sahar N Saleem; William B Dobyns; A James Barkovich; Hauke Bartsch; Anders M Dale; Manzar Ashtari; Naiara Akizu; Joseph G Gleeson; Ana Maria Grijalvo-Perez Journal: Brain Date: 2012-07-20 Impact factor: 13.501
Authors: Yasmin Namavar; David Chitayat; Peter G Barth; Fred van Ruissen; Marit B de Wissel; Bwee Tien Poll-The; Rachel Silver; Frank Baas Journal: Eur J Hum Genet Date: 2011-02-02 Impact factor: 4.246
Authors: Michael A Rosenberg; Robert C Kaplan; David S Siscovick; Bruce M Psaty; Susan R Heckbert; Christopher Newton-Cheh; Kenneth J Mukamal Journal: Am J Epidemiol Date: 2014-06-18 Impact factor: 4.897
Authors: Ender Karaca; Tamar Harel; Davut Pehlivan; Shalini N Jhangiani; Tomasz Gambin; Zeynep Coban Akdemir; Claudia Gonzaga-Jauregui; Serkan Erdin; Yavuz Bayram; Ian M Campbell; Jill V Hunter; Mehmed M Atik; Hilde Van Esch; Bo Yuan; Wojciech Wiszniewski; Sedat Isikay; Gozde Yesil; Ozge O Yuregir; Sevcan Tug Bozdogan; Huseyin Aslan; Hatip Aydin; Tulay Tos; Ayse Aksoy; Darryl C De Vivo; Preti Jain; B Bilge Geckinli; Ozlem Sezer; Davut Gul; Burak Durmaz; Ozgur Cogulu; Ferda Ozkinay; Vehap Topcu; Sukru Candan; Alper Han Cebi; Mevlit Ikbal; Elif Yilmaz Gulec; Alper Gezdirici; Erkan Koparir; Fatma Ekici; Salih Coskun; Salih Cicek; Kadri Karaer; Asuman Koparir; Mehmet Bugrahan Duz; Emre Kirat; Elif Fenercioglu; Hakan Ulucan; Mehmet Seven; Tulay Guran; Nursel Elcioglu; Mahmut Selman Yildirim; Dilek Aktas; Mehmet Alikaşifoğlu; Mehmet Ture; Tahsin Yakut; John D Overton; Adnan Yuksel; Mustafa Ozen; Donna M Muzny; David R Adams; Eric Boerwinkle; Wendy K Chung; Richard A Gibbs; James R Lupski Journal: Neuron Date: 2015-11-04 Impact factor: 17.173